Medivir Ser B Sek5 (CE) (MVRBF)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current MVRBF market cap is 91.88M. The company's latest EPS is SEK -0.7971 and P/E is -1.03.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 11.38M | 38.61M | 33.46M | 4.97M | 7.66M |
| Operating Income | -125.98M | -45.55M | -64.4M | -88.61M | -92.75M |
| Net Income | -123.44M | -42.62M | -63.13M | -88.77M | -89.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 293.46M | 191.46M | 335.83M | 234.2M | 287.91M |
| Total Liabilities | 109.01M | 49.56M | 54.68M | 41.41M | 69.99M |
| Total Equity | 184.46M | 141.91M | 281.15M | 192.79M | 217.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -148.26M | -58.05M | -48.73M | -101.82M | -59.67M |
| Investing | 4.49M | 5.37M | N/A | -382k | -261k |
| Financing | -6.66M | -12.12M | 199.4M | -1.53M | 112.07M |
| Market Cap | 91.88M |
| Price to Earnings Ratio | -1.03 |
| Price to Sales Ratio | 11.99 |
| Price to Cash Ratio | 3.6 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 112.05M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Medivir Ser B Sek5 (CE) |
| Address |
lunastigen 5, 2nd floor huddinge SE-141 22 |
| Website | https://www.medivir.se |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
